- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Article 2(2)(a)
Column 1 | Column 2 | Column 3 | Column 4 |
---|---|---|---|
Substance | Maximum strength | Use, pharmaceutical form or route of administration | Maximum dose and maximum daily dose |
Choline Bitartrate | |||
Equisetum | |||
Ibuprofen | (1) 200 mg | (1) Internal: tablets, capsules, powder or granules, in each case for use in adults and in children over the age of 12 years only and for treatment of the following only–
| (1) 400 mg (MD) 1200 mg (MDD) |
(2) 5.0 per cent. | (2) External: for use in adults and in children over the age of 12 years only and for treatment of the following only–
| (2) 125 mg (MD) 500 mg (MDD) | |
Magnesium Alginate |
Article 2(3)
Column 1 | Column 2 | Column 3 |
---|---|---|
Substance | Maximum strength | Use, pharmaceutical form or route of administration |
Capsicum Oleoresin | ||
Capsicum Oleoresin (Water soluble) | ||
Clotrimazole | 1.0 per cent. | For treatment of tinea pedis (athlete’s foot) only |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: